Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

VANI Vivani Medical Inc

Price (delayed)

$1.12

Market cap

$66.35M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.43

Enterprise value

$69.64M

Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in ...

Highlights
The debt has decreased by 13% YoY
The EPS is up by 12% year-on-year
The equity has plunged by 60% YoY and by 34% from the previous quarter
The company's quick ratio has shrunk by 54% YoY and by 30% QoQ

Key stats

What are the main financial stats of VANI
Market
Shares outstanding
59.24M
Market cap
$66.35M
Enterprise value
$69.64M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.71
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Operating income
-$25.01M
Net income
-$23.75M
EBIT
-$23.75M
EBITDA
-$23.09M
Free cash flow
-$21.82M
Per share
EPS
-$0.43
EPS diluted
-$0.43
Free cash flow per share
-$0.37
Book value per share
$0.2
Revenue per share
$0
TBVPS
$0.6
Balance sheet
Total assets
$35.45M
Total liabilities
$23.83M
Debt
$17.63M
Equity
$11.62M
Working capital
$8.65M
Liquidity
Debt to equity
1.52
Current ratio
2.4
Quick ratio
2.31
Net debt/EBITDA
-0.14
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-56.5%
Return on equity
-133.1%
Return on invested capital
-68.9%
Return on capital employed
-81.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

VANI stock price

How has the Vivani Medical stock price performed over time
Intraday
-1.75%
1 week
-1.75%
1 month
7.69%
1 year
-31.71%
YTD
-3.45%
QTD
6.67%

Financial performance

How have Vivani Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$25.01M
Net income
-$23.75M
Gross margin
N/A
Net margin
N/A
Vivani Medical's net income has increased by 6% YoY
VANI's operating income is up by 6% YoY

Price vs fundamentals

How does VANI's price correlate with its fundamentals

Growth

What is Vivani Medical's growth rate over time

Valuation

What is Vivani Medical stock price valuation
P/E
N/A
P/B
5.71
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 12% year-on-year
The equity has plunged by 60% YoY and by 34% from the previous quarter
VANI's price to book (P/B) is 46% more than its last 4 quarters average of 3.9 but 8% less than its 5-year quarterly average of 6.2

Efficiency

How efficient is Vivani Medical business performance
The return on equity has declined by 42% year-on-year and by 25% since the previous quarter
The return on assets has declined by 18% year-on-year and by 12% since the previous quarter
Vivani Medical's return on invested capital has decreased by 5% YoY and by 4.4% QoQ

Dividends

What is VANI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VANI.

Financial health

How did Vivani Medical financials performed over time
The total assets is 49% more than the total liabilities
The company's quick ratio has shrunk by 54% YoY and by 30% QoQ
Vivani Medical's current ratio has shrunk by 53% YoY and by 30% QoQ
The debt is 52% higher than the equity
VANI's debt to equity has surged by 114% year-on-year and by 49% since the previous quarter
The equity has plunged by 60% YoY and by 34% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.